1st Quarter - Report

CAPITOL HILL CONSULTING GROUP for NOVARTIS CORPORATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General healthcare issues related to pharmaceutical and biological products; Federal, Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); drug safety; Food and Drug Administration Amendments Act of 2007 (Public Law No:110-85); FDA Globalization Act (HR 759); Follow-on biologics: American Recovery and Reinvestment Act of 2009 (Public Law No. 111-5)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 759 (111th)

Government Issues GOV

general patent issues

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement; Physician gifts; Physician Payments Sunshine Ace (S. 2029); Drug and Medical Device Company Gift Disclosure Act (HR 3023); False Claims Act Correction Act (HR 4854/S. 2041)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3023 (111th), S. 2041 (111th), H.R. 4854 (111th), S. 2029 (111th)

Budget/Appropriations BUD

FDA funding issues, generally, FY2009 Labor-HHS Appropriations; FY 2009 Department of Defense Appropriations; FY 2009 Supplemental Appropriations. Vaccines: Funding for the Transformational Medical Technologies Initiative (TMTI)

LobbyistCovered position, as disclosed
BILL K BREWSTER —
STEVEN E IRIZARRY —
DAVID JORY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.